Dr. Ina Albert

Persönliches Profil

Tätigkeit an der ZHAW

wissenschaftliche Mitarbeiterin

www.zhaw.ch/en/lsfm/institutes-centres/icbt/drug-discovery-and-pharmaceutical-product-development/

Aus- und Fortbildung

2017-2019
DAS in Pharmaceutical Medicine
University Basel, European Center of Pharmaceutical Medicine (ECPM)

2019
CAS in Clinical Trial Management
University Hospital Zuerich, Clinical Trial Center (CTC)

2011 – 2014:
Doctoral Program „Medical Science“ at Private University of Principality of Liechtenstein in Triesen (FL)

2004-2008:
Study program Pharma-Biotechnology at Ernst-Abbe-Fachhochschule Jena

Projekte

• Molekulare Analyse von CD30+ Lymphoma / Stellv. ProjektleiterIn / Projekt abgeschlossen
• Thermoplan - Nachweis Marker-Verbindungen Milch / Teammitglied / Projekt abgeschlossen
• Modulatoren der MMP-Hemopexin-Domäne / Teammitglied / Projekt abgeschlossen
• Novel Antimicrobials for Life-Threatening Infections / Stellv. ProjektleiterIn / Projekt abgeschlossen
• Dynamic combinatorial chemistry in drug discovery / Teammitglied / Projekt abgeschlossen

Publikationen

• Iliescu, Iolanda Alca; Peter, Samuel; Albert, Ina; Skalicka‐Woźniak, Krystyna; Miron, Anca; Luca, Simon Vlad; Wolfram, Evelyn,

  2020.

  Verbascum nigrum : cytotoxicity evaluation in A431 epidermoid carcinoma cells and untargeted LC‐HR‐MS/MS metabolite profiling.

  Chemistry & Biodiversity.

  17(12), S. e2000644.

  Verfügbar unter: https://doi.org/10.1002/cbdv.202000644

• Iliescu, Iolanda Alca; Bräm, Sarah; Peter, Samuel; Meier, Nadja; Albert, Ina; Miron, Anca; Wolfram, Evelyn,

  2015.

  Phytochemical fingerprints combined with bioautographic enzyme inhibition and antitumor activity of Verbascum (Scrophulariaceae) and Ajuga (Lamiaceae) plant extractives on skin squamous cell carcinoma.

  Planta Medica.

  81(PW_208).

  Verfügbar unter: https://doi.org/10.1055/s-0035-1565832

• Antoni, PM; Naik, A; Albert, Ina; Rubbiani, R; Gupta, S; Ruiz-Sanchez, P; Munikorn, P; Mateos, JM; Luginbühl, Vera; Thamyongkit, P; Ziegler, U; Gasser, G; Jeschke, G; Spingler, Bernhard,

  2014.

  (Metallo)porphyrins as potent phototoxic anti-cancer agents after irradiation with red light.

  Chemistry - A European Journal.

  21(3), S. 1-6.

  Verfügbar unter: https://doi.org/10.1002/chem.201405470

• Albert, Ina; Hefti, Martin; Luginbühl, Vera,

  2014.

  Physiological oxygen concentration alters glioma cell malignancy and responsiveness to photodynamic therapy in vitro.

  Neurological Research.

  36(11), S. 1001-1010.

  Verfügbar unter: https://doi.org/10.1179/1743132814Y.0000000401

• Hefti, Martin; Albert, Ina; Luginbühl, Vera,

  2012.

  Phenytoin reduces 5-aminolevulinic acid-induced protoporphyrin IX accumulation in malignant glioma cells.

  Journal of Neuro-Oncology.

  108(3), S. 443-450.

  Verfügbar unter: https://doi.org/10.1007/s11060-012-0857-9

• Hefti, Martin; Holenstein, Fabian; Albert, Ina; Looser, Herbert; Luginbühl, Vera,

  2011.

  Susceptibility to 5-aminolevulinic acid based photodynamic therapy in WHO I meningioma cells corresponds to ferrochelatase activity.

  Photochemistry and Photobiology.

  87(1), S. 235-241.

  Verfügbar unter: https://doi.org/10.1111/j.1751-1097.2010.00821.x

• Luginbühl, Vera; Albert, Ina; Hefti, Martin,

  2011.

  Fotodynamische Diagnostik und Therapie von malignen Hirntumoren.

  Management & Krankenhaus.

Zurück